Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feride Frech

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Health Affairs (Project Hope)|January 7, 2011
A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnessesTeresa B Gibson, Sara Wang, Emily Kelly, et al.
Vascular Health and Risk Management|August 1, 2013
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up reportCarlos M Ferrario, Janae Joyner, Chris Colby, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 9, 2007
Ethnic/racial variations in blood pressure awareness, treatment, and controlThomas Giles, Juan M Aranda, Dong-Churl Suh, et al.
Patient Related Outcome Measures|February 17, 2022
Patient-Reported Outcome Measures in Adult Patients Diagnosed with Epilepsy Being Treated with PerampanelBrian D Moseley, Shaloo Gupta, Nate Way, et al.
Epilepsy & Behavior : E&B|April 3, 2021
Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United StatesFrançois Laliberté, Mei Sheng Duh, Victoria Barghout, et al.
Archives of Internal Medicine|April 30, 2003
The economic consequences of irritable bowel syndrome: a US employer perspectiveStephanie A Leong, Victoria Barghout, Howard G Birnbaum, et al.
The American Journal of Gastroenterology|March 26, 2003
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspectiveGeorge F Longstreth, Alisa Wilson, Kevin Knight, et al.
Neurology and Therapy|May 4, 2025
Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence StudyMarwan N Sabbagh, Chenyue Zhao, Malena Mahendran, et al.
Managed Care Interface|March 25, 2004
Quality of life in managed care patients with irritable bowel syndromeAlisa Wilson, George F Longstreth, Kevin Knight, et al.
Journal of Medical Economics|June 19, 2015
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelorCliff Molife, Feride Frech-Tamas, Mitch DeKoven, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Health Affairs (Project Hope)|January 7, 2011
A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnessesTeresa B Gibson, Sara Wang, Emily Kelly, et al.
Vascular Health and Risk Management|August 1, 2013
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up reportCarlos M Ferrario, Janae Joyner, Chris Colby, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 9, 2007
Ethnic/racial variations in blood pressure awareness, treatment, and controlThomas Giles, Juan M Aranda, Dong-Churl Suh, et al.
Patient Related Outcome Measures|February 17, 2022
Patient-Reported Outcome Measures in Adult Patients Diagnosed with Epilepsy Being Treated with PerampanelBrian D Moseley, Shaloo Gupta, Nate Way, et al.
Epilepsy & Behavior : E&B|April 3, 2021
Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United StatesFrançois Laliberté, Mei Sheng Duh, Victoria Barghout, et al.
Archives of Internal Medicine|April 30, 2003
The economic consequences of irritable bowel syndrome: a US employer perspectiveStephanie A Leong, Victoria Barghout, Howard G Birnbaum, et al.
The American Journal of Gastroenterology|March 26, 2003
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspectiveGeorge F Longstreth, Alisa Wilson, Kevin Knight, et al.
Neurology and Therapy|May 4, 2025
Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence StudyMarwan N Sabbagh, Chenyue Zhao, Malena Mahendran, et al.
Managed Care Interface|March 25, 2004
Quality of life in managed care patients with irritable bowel syndromeAlisa Wilson, George F Longstreth, Kevin Knight, et al.
Journal of Medical Economics|June 19, 2015
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelorCliff Molife, Feride Frech-Tamas, Mitch DeKoven, et al.
Pageof 5